Mumbai-headquartered Bharat Serums and Vaccines Limited (BSV) hosted the groundbreaking ceremony of its new manufacturing plant at Genome Valley in Hyderabad, Telengana. The company is owned by Advent, an American private equity fund. Spread across 10 acres, the $22 million manufacturing facility will increase the company's capacity to produce injectables...
Biological E Invest $234 Million to Expand Vaccine Production
Privately held Indian company, Biological E is investing $234 million in their three facilities in the Genome Valley of Hyderabad, India. The new infusion of funds will enhance the production capacity by five billion doses, increasing the cumulative capacity to about 14 billion doses per year. The company claims that...